Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area

Sarah S. Lewis; Becky A. Smith; Ibukunoluwa C. Akinboyo; Jessica Seidelman; Cameron Wolfe; Allan B. Kirk; Gavin Martin; Thomas Denny; Bruce Lobaugh; Catherine Rehder; Diana Cardona; Mark J. Lee; Christopher R. Polage; Michael B. Datto

doi:10.1017/ice.2020.398

Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area

Sarah S. Lewis^*
, Becky A. Smith
, Ibukunoluwa C. Akinboyo
, Jessica Seidelman
, Cameron Wolfe
, Allan B. Kirk
, Gavin Martin
, Thomas Denny
, Bruce Lobaugh
, Catherine Rehder
, Diana Cardona
, Mark J. Lee
, Christopher R. Polage
, Michael B. Datto

^*Corresponding author for this work

Surgery

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.

Original language	English
Pages (from-to)	341-343
Number of pages	3
Journal	Infection Control and Hospital Epidemiology
Volume	42
Issue number	3
DOIs	https://doi.org/10.1017/ice.2020.398
State	Published - Mar 2021

Access to Document

10.1017/ice.2020.398

Cite this

Lewis, S. S., Smith, B. A., Akinboyo, I. C., Seidelman, J., Wolfe, C., Kirk, A. B., Martin, G., Denny, T., Lobaugh, B., Rehder, C., Cardona, D., Lee, M. J., Polage, C. R., & Datto, M. B. (2021). Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area. Infection Control and Hospital Epidemiology, 42(3), 341-343. https://doi.org/10.1017/ice.2020.398

@article{6eeeacbbf48140b38995a0c9c644e923,

title = "Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area",

abstract = "We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5\%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.",

author = "Lewis, \{Sarah S.\} and Smith, \{Becky A.\} and Akinboyo, \{Ibukunoluwa C.\} and Jessica Seidelman and Cameron Wolfe and Kirk, \{Allan B.\} and Gavin Martin and Thomas Denny and Bruce Lobaugh and Catherine Rehder and Diana Cardona and Lee, \{Mark J.\} and Polage, \{Christopher R.\} and Datto, \{Michael B.\}",

note = "Publisher Copyright: {\textcopyright} ",

year = "2021",

month = mar,

doi = "10.1017/ice.2020.398",

language = "English",

volume = "42",

pages = "341--343",

journal = "Infection Control and Hospital Epidemiology",

issn = "0899-823X",

publisher = "Cambridge University Press",

number = "3",

}

Lewis, SS, Smith, BA, Akinboyo, IC, Seidelman, J, Wolfe, C, Kirk, AB, Martin, G, Denny, T, Lobaugh, B, Rehder, C, Cardona, D, Lee, MJ, Polage, CR & Datto, MB 2021, 'Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area', Infection Control and Hospital Epidemiology, vol. 42, no. 3, pp. 341-343. https://doi.org/10.1017/ice.2020.398

TY - JOUR

T1 - Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area

AU - Lewis, Sarah S.

AU - Smith, Becky A.

AU - Akinboyo, Ibukunoluwa C.

AU - Seidelman, Jessica

AU - Wolfe, Cameron

AU - Kirk, Allan B.

AU - Martin, Gavin

AU - Denny, Thomas

AU - Lobaugh, Bruce

AU - Rehder, Catherine

AU - Cardona, Diana

AU - Lee, Mark J.

AU - Polage, Christopher R.

AU - Datto, Michael B.

PY - 2021/3

Y1 - 2021/3

N2 - We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.

AB - We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.

UR - https://www.scopus.com/pages/publications/85089580027

U2 - 10.1017/ice.2020.398

DO - 10.1017/ice.2020.398

M3 - Article

C2 - 32741409

AN - SCOPUS:85089580027

SN - 0899-823X

VL - 42

SP - 341

EP - 343

JO - Infection Control and Hospital Epidemiology

JF - Infection Control and Hospital Epidemiology

IS - 3

ER -

Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area

Abstract

Access to Document

Fingerprint

Cite this